Optimizing the use of angiogenesis inhibitor in neovascular age-related macular degeneration

The purpose of the study was to estimate the effectiveness of using ranibizumab in combination with medotilin drug in the treatment of neovascular age-related macular degeneration (AMD). Material and methods. 50 patients (65 eyes) aged 41 to 88 (ave. 68.5 ± 0.98 years) with neovascular AMD were foll...

Descrizione completa

Dettagli Bibliografici

Autori principali:	F. A. Bakhritdinova, A. F. Yusupov, Sh. A. Mukhanov
Natura:	Artigo
Lingua:	Russo
Pubblicazione:	Real Time Ltd 2018-10-01
Serie:	Российский офтальмологический журнал
Soggetti:	возрастная макулярная дегенерация хроническая неоваскуляризация ранибизумаб медотилин электроретинография age-related macular degeneration chronic neovascularization ranibizumab medotilin electroretinography
Accesso online:	https://roj.igb.ru/jour/article/view/69
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!